Published in J Control Release on March 22, 2011
Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J Control Release (2012) 0.90
Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines. Expert Opin Drug Deliv (2013) 0.85
Transcutaneous vaccination via laser microporation. J Control Release (2012) 0.82
An update on the use of laser technology in skin vaccination. Expert Rev Vaccines (2013) 0.81
Feasibility of ablative fractional laser-assisted drug delivery with optical coherence tomography. Biomed Opt Express (2014) 0.78
Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing : optimization of the applied dose for postoperative care. Lasers Med Sci (2013) 0.78
[New developments in laser therapy]. Hautarzt (2012) 0.77
Laser-assisted drug delivery in dermatology: from animal models to clinical practice. Lasers Med Sci (2015) 0.77
Sustained epidermal powder drug delivery via skin microchannels. J Control Release (2017) 0.75
Percutaneous bone marrow transplantation using fractional ablative Erbium:YAG laser. PLoS One (2014) 0.75
Skin resurfacing procedures: new and emerging options. Clin Cosmet Investig Dermatol (2014) 0.75
Evaluation of Laser-Assisted Trans-Nail Drug Delivery with Optical Coherence Tomography. Sensors (Basel) (2016) 0.75
Transdermal delivery of three vitamin C derivatives by Er:YAG and carbon dioxide laser pretreatment. Lasers Med Sci (2012) 0.75
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharm Res (2012) 1.43
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 1.35
Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol (2005) 1.30
Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis (2008) 1.26
The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev Biol (2008) 1.24
Brand and generic medications: are they interchangeable? Ann Saudi Med (2008) 1.19
Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol (2002) 1.16
Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol (2002) 1.15
12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression. J Cell Physiol (2010) 1.10
Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells. Int J Cancer (2007) 1.09
Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J Invest Dermatol (2003) 1.06
Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochem Pharmacol (2003) 1.04
Microdermabrasion as a novel tool to enhance drug delivery via the skin: an animal study. Dermatol Surg (2006) 1.02
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation. Neurobiol Dis (2009) 1.00
Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages. J Cell Physiol (2005) 0.99
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm (2010) 0.99
(-)-Epicatechin-3-gallate, a green tea polyphenol is a potent agent against UVB-induced damage in HaCaT keratinocytes. Molecules (2007) 0.99
Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther (2005) 0.99
Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release (2006) 0.98
Baicalein inhibition of hydrogen peroxide-induced apoptosis via ROS-dependent heme oxygenase 1 gene expression. Biochim Biophys Acta (2007) 0.98
Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas. J Dermatol Sci (2007) 0.97
Transdermal delivery of macromolecules by erbium:YAG laser. J Control Release (2004) 0.97
Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. J Pharm Sci (2009) 0.96
Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim Biophys Acta (2004) 0.95
Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules (2009) 0.95
The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci (2002) 0.94
Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol Appl Pharmacol (2006) 0.94
In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int J Pharm (2008) 0.92
Anthraquinones from Polygonum cuspidatum as tyrosinase inhibitors for dermal use. Phytother Res (2008) 0.92
Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways. Biochem Biophys Res Commun (2009) 0.91
Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem Pharmacol (2005) 0.91
Zeaxanthin inhibits PDGF-BB-induced migration in human dermal fibroblasts. Exp Dermatol (2010) 0.90
Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin. Hum Gene Ther (2009) 0.89
In vitro and in vivo anti-photoaging effects of an isoflavone extract from soybean cake. J Ethnopharmacol (2009) 0.88
Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J Control Release (2008) 0.88
Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol Pharm Bull (2008) 0.87
Chrysin protects epidermal keratinocytes from UVA- and UVB-induced damage. J Agric Food Chem (2011) 0.87
Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser. J Control Release (2010) 0.87
Noninvasive glucose monitoring by back diffusion via skin: chemical and physical enhancements. Biol Pharm Bull (2003) 0.86
Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J (2013) 0.86
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine (2010) 0.86
Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res (2010) 0.86
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm (2011) 0.86
The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion. Int J Pharm (2006) 0.86
Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids. Biochem Pharmacol (2003) 0.85
The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int J Pharm (2005) 0.85
Protective effects of myricetin against ultraviolet-B-induced damage in human keratinocytes. Toxicol In Vitro (2009) 0.85
Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci (2006) 0.85
Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J Drug Target (2011) 0.85
Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J Pharm Sci (2010) 0.85
Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin. J Pharm Sci (2010) 0.85
Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-κB and AP-1 activation in macrophages. J Dermatol Sci (2012) 0.85
Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int J Nanomedicine (2012) 0.84
Physicochemical characterization and gene transfection efficiency of lipid emulsions with various co-emulsifiers. Int J Pharm (2004) 0.84
Reciprocal activation of macrophages and breast carcinoma cells by nitric oxide and colony-stimulating factor-1. Carcinogenesis (2010) 0.84
A comparison of skin delivery of ferulic acid and its derivatives: evaluation of their efficacy and safety. Int J Pharm (2010) 0.84
Evaluation of drug and sunscreen permeation via skin irradiated with UVA and UVB: comparisons of normal skin and chronologically aged skin. J Dermatol Sci (2012) 0.84
Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. Chem Pharm Bull (Tokyo) (2011) 0.84
12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells. Apoptosis (2006) 0.84
Inhibition of HSP90-dependent telomerase activity in amyloid β-induced apoptosis of cerebral endothelial cells. J Cell Physiol (2011) 0.84
The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells. J Cell Physiol (2012) 0.83
The influence of cardiopulmonary resuscitation without defibrillation on serum levels of cardiac enzymes: a time course study of out-of-hospital cardiac arrest survivors. Resuscitation (2005) 0.83
Nicotine enhancement of lipopolysaccharide/interferon-gamma-induced cytotoxicity with elevating nitric oxide production. Toxicol Lett (2004) 0.83
Initial steps in anoxic testosterone degradation by Steroidobacter denitrificans. Microbiology (2010) 0.83
Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol (2006) 0.83
Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis. J Exp Clin Cancer Res (2010) 0.83
Hydroxylation at C4' or C6 is essential for apoptosis-inducing activity of flavanone through activation of the caspase-3 cascade and production of reactive oxygen species. Free Radic Biol Med (2004) 0.83
Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. J Control Release (2006) 0.83
In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. J Pharm Sci (2006) 0.82
Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation. Lasers Surg Med (2008) 0.82
Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med (2013) 0.82
Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J Microencapsul (2009) 0.82
Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol (2013) 0.82
Wogonin but not Nor-wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages. Int Immunopharmacol (2007) 0.82
Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol (2004) 0.82
Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells. J Dermatol Sci (2011) 0.82
Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv (2014) 0.82
Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull (2013) 0.82
CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol Med (2012) 0.82
Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur J Pharm Sci (2009) 0.81
Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk. Food Chem Toxicol (2012) 0.81
Cytotoxic effects of metal protoporphyrins in glioblastoma cells: roles of albumin, reactive oxygen species, and heme oxygenase-1. Toxicol Lett (2008) 0.81
Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin Drug Deliv (2008) 0.81
Nuclear betaII-tubulin associates with the activated notch receptor to modulate notch signaling. Cancer Res (2004) 0.81
Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm (2010) 0.81
Skin toxicology of lead species evaluated by their permeability and proteomic profiles: a comparison of organic and inorganic lead. Toxicol Lett (2010) 0.81
Vitamin K3-2,3-epoxide induction of apoptosis with activation of ROS-dependent ERK and JNK protein phosphorylation in human glioma cells. Chem Biol Interact (2011) 0.81